Inventor · disambiguated record
Subramanya Hosahalli
Also filed as: HOSAHALLI SUBRAMANYA · HOSAHALLI SUBRAMANYA SEETHARAMA SHASTRY
18 granted patents·9 pending applications·73 citations·filing 2011–2021
92Inventor score
Files withAURIGENE DISCOVERY TECH LTD10ASANA BIOSCIENCES LLC7ENDO PHARMACEUTICALS INC2ORION CORP2ABBVIE INC1
Top patents by PatentIndex Score
27 records- 0193US9937155B2Methods of use for trisubstituted benzotriazole derivatives as dihydroorotate oxygenase inhibitorsAURIGENE DISCOVERY TECH LTD·Filed 2017·Granted Apr 10, 2018·6 cites·40 claims
- 0291US9630932B2Trisubstituted benzotriazole derivatives as dihydroorotate oxygenase inhibitorsAURIGENE DISCOVERY TECH LTD·Filed 2014·Granted Apr 25, 2017·13 cites·40 claims
- 0389US10080740B2Trisubstituted benzotriazole derivatives as dihydroorotate oxygenase inhibitorsAURIGENE DISCOVERY TECH LTD·Filed 2017·Granted Sep 25, 2018·6 cites·12 claims
- 0488US9062075B2Tetrahydropyridine derivatives as FabI inhibitorsAURIGENE DISCOVERY TECH LTD·Filed 2014·Granted Jun 23, 2015·8 cites·19 claims
- 0587US11147801B2Methods of use for trisubstituted benzotriazole derivatives as dihydroorotate oxygenase inhibitorsAURIGENE DISCOVERY TECH LTD·Filed 2018·Granted Oct 19, 2021·4 cites·12 claims
- 0686US9382277B2Pyrimido-pyridazinone compounds and methods of use thereofASANA BIOSCIENCES LLC·Filed 2014·Granted Jul 5, 2016·8 cites·28 claims
- 0782US8729079B2Pyrimido-pyridazinone compounds and methods of use thereofVENKATESAN ARANAPAKAM·Filed 2012·Granted May 20, 2014·8 cites·25 claims
- 0881US9062002B2Substituted pyridine derivatives as FabI inhibitorsAURIGENE DISCOVERY TECH LTD·Filed 2012·Granted Jun 23, 2015·8 cites·19 claims
- 0981US8440662B2Substituted quinazoline and pyrido-pyrimidine derivativesSMITH ROGER ASTBURY·Filed 2011·Granted May 14, 2013·9 cites·46 claims
- 1080US10647720B2Pyrimido-pyridazinone compounds and methods of use thereofASANA BIOSCIENCES LLC·Filed 2018·Granted May 12, 2020·1 cites·33 claims
- 1174US10077259B2Bicyclic heterocyclic derivatives as bromodomain inhibitorsORION CORP·Filed 2015·Granted Sep 18, 2018·2 cites·11 claims
- 1272US2021113578A1Quinazolines and azaquinazolines as dual inhibitors of ras/raf/mek/erk and pi3k/akt/pten/mtor pathwaysASANA BIOSCIENCES LLC·Filed 2020·Application pending·0 cites
- 1370US10912779B2Quinazolines and azaquinazolines as dual inhibitors of RAS/RAF/MEK/ERK and PI3K/AKT/PTEN/mTOR pathwaysASANA BIOSCIENCES LLC·Filed 2019·Granted Feb 9, 2021·0 cites·23 claims
- 1468US12290507B2Methods of use for trisubstituted benzotriazole derivatives as dihydroorotate oxygenase inhibitorsAURIGENE ONCOLOGY LTD·Filed 2021·Granted May 6, 2025·0 cites·4 claims
- 1566US2020190095A1Pyrimido-pyridazinone compounds and methods of use thereofASANA BIOSCIENCES LLC·Filed 2020·Application pending·0 cites
- 1666US2019105304A1Trisubstituted benzotriazole derivatives as dihydroorotate oxygenase inhibitorsAURIGENE DISCOVERY TECH LTD·Filed 2018·Application pending·0 cites
- 1759US9115092B2Substituted quinazoline and pyrido-pyrimidine derivativesASANA BIOSCIENCES LLC·Filed 2014·Granted Aug 25, 2015·0 cites·12 claims
- 1857US2014073782A1Substituted Quinazoline and Pyrido-Pyrimidine DerivativesENDO PHARMACEUTICALS INC·Filed 2013·Application pending·0 cites
- 1956US2013190492A1Substituted quinazoline and pyrido-pyrimidine derivativesENDO PHARMACEUTICALS INC·Filed 2013·Application pending·0 cites
- 2054US2018369206A1Methods of Use for Trisubstituted Benzotriazole Derivatives as Dihydroorotate Oxygenase InhibitorsAURIGENE DISCOVERY TECH LTD·Filed 2018·Application pending·0 cites
- 2150US10590118B2Bicyclic heterocyclic derivatives as bromodomain inhibitorsORION CORP·Filed 2018·Granted Mar 17, 2020·0 cites·9 claims
- 2242US9029409B2Isoxazolines as therapeutic agentsCALDERWOOD DAVID J·Filed 2012·Granted May 12, 2015·0 cites·17 claims
- 2341US11028054B21, 4, 6-trisubstituted-2-alkyl-1H-benzo[d]imidazole derivatives as dihydroorotate oxygenase inhibitorsMERCK PATENT GMBH·Filed 2018·Granted Jun 8, 2021·0 cites·156 claims
- 2441US2016016952A1Substituted amino-pyrimidine derivativesASANA BIOSCIENCES LLC·Filed 2015·Application pending·0 cites
- 2539US2015183781A15-(1H-Pyrazol-4-yl)-1H-Pyrrolo[2,3-b]Pyridine Derivatives as Kinase InhibitorsAURIGENE DISCOVERY TECH LTD·Filed 2013·Application pending·0 cites
- 2638US9353107B23-(pyrazolyl)-1H-pyrrolo[2,3-b]pyridine derivatives as kinase inhibitorsAURIGENE DISCOVERY TECH LTD·Filed 2013·Granted May 31, 2016·0 cites·17 claims
- 2737US2015297596A1Isoxazolines as therapeutic agentsABBVIE INC·Filed 2015·Application pending·0 cites
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →